Dr. Suganya Kannan serves as the Pharmacovigilance Manager at DP Clinical. She provides leadership and direction to the Pharmacovigilance Department and project teams to ensure the safety of human subjects and integrity of data collected in clinical trials. She is a medically trained professional whose breadth of knowledge includes pharmacovigilance as well as data management for Phase I, II, and III clinical studies. Dr. Kannan has experience with regulatory reporting guidelines, SUSAR submissions, serious adverse reporting guidelines, clinical data reviews, medical coding reviews, protocol reviews, and clinical experience in treating patients. Her therapeutic experience includes working with clinical trials involving breast cancer, gastrointestinal tract tumors, glioma, leukemia, lung cancer, lymphoma, pancreatic cancer, and prostate cancer.
Prior to DP Clinical, Dr. Kannan was a Pharmacovigilance Specialist at an oncology CRO, working on commercial Sponsor studies and as a Data Manager at the National Cancer Institute (NCI) funded oncology clinical trials.
Dr. Kannan holds a Master’s degree in Clinical and Translational Science (MCTS) from Rutgers University, New Jersey, and an MBBS degree from Dr. MGR Medical University, India.
